AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9589267
Drug: Buprenorphine 2
RxNorm normalized name: buprenorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 2 mg
Trial: 10463317
Drug: Buprenorphine 8
RxNorm normalized name: buprenorphine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 8 mg
Trial: 21904686
Drug: Buprenorphine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (2 mg and 8 mg)
Trial: 10516884
Drug: Pramipexole 0.75
RxNorm normalized name: pramipexole 0.75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole 0.75 mg/d
Trial: 9214527
Drug: Pramipexole 4.5
RxNorm normalized name: pramipexole 4.5 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole 4.5 mg/d
Trial: 7011249
Drug: Low-dose haloperidol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose haloperidol
Trial: 27140801
Drug: Thrombomodulin alfa
RxNorm normalized name: Thrombomodulin Alfa
DrugBank: Thrombomodulin Alfa (DB05777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombomodulin alfa (0.02 mg/kg)
Trial: 25466666
Drug: Glutamine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (30 g/d)
Trial: 29104459
Drug: Placebo (casein,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (casein, 30 g/d)
Trial: 25039544
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline
Trial: 11280555
Drug: Alosetron 1
RxNorm normalized name: alosetron 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alosetron 1 mg b.i.d.
Trial: 9402351
Drug: Furazolidone combined
RxNorm normalized name: Furazolidone
DrugBank: Furazolidone (DB00614)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furazolidone combined with bismuth subsalicylate and amoxicillin
Trial: 9402351
Drug: Testing for
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testing for antibodies to H. pylori
Trial: 8219653
Drug: Normal vs
RxNorm normalized name: VS-4718
DrugBank: VS-4718 (DB15273)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal vs elevated urinary albumin excretion
Trial: 8219653
Drug: Increased urinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased urinary albumin and alpha-1-microglobulin excretion
Trial: 7272174
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) 30 mg
Trial: 3304705
Drug: N-acetylcysteine 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine 100 mg/kg
Trial: 23958608
Drug: Ice pack
RxNorm normalized name: Ice Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice pack therapy for 10 minutes
Trial: 23958608
Drug: Ice pack
RxNorm normalized name: Ice Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice pack therapy for 20 minutes
Trial: 23958608
Drug: Ice pack
RxNorm normalized name: Ice Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ice pack therapy for 30 minutes
Trial: 18996379
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy with porfimer sodium combined with acid suppression (PHOPDT)
Trial: 18996379
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole twice daily (control)
Trial: 8378890
Drug: Breast‐preserving therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast‐preserving therapy (BCT)
Trial: 3137593
Drug: Intravenous nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous nicotine (0.5 microgram/kg/min)
Trial: 23190756
Drug: Low amount
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low amount of dairy food (LD), equivalent to ≤238 mL/d milk
Trial: 22097203
Drug: Calcichew D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcichew D3 Tablet
Trial: 22097203
Drug: Calcichew D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcichew D3 Tablet and Xianling Gubao Capsule
Trial: 22097203
Drug: Calcichew D5
RxNorm normalized name: VITAMIN D5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcichew D5 Tablet and embedding thread according to staging and wholism syndrome differentiation
Trial: 19541504
Drug: Placebo (220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (220 mg corn starch)
Trial: 16274713
Drug: Heat therapy
RxNorm normalized name: CVS Neck Arm & Leg Heat Therapy Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat therapy (50 degrees C for 30s, applied once)
Trial: 16274713
Drug: Glucantime therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucantime therapy (antimonial, administered for 20 days)
Trial: 23746110
Drug: Heat therapy
RxNorm normalized name: CVS Neck Arm & Leg Heat Therapy Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat therapy
Trial: 16274713
Drug: Glucantime therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucantime therapy
Trial: 9028548
Drug: 5 micrograms/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 micrograms/kg/day G-CSF
Trial: 9028548
Drug: 10 micrograms/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms/kg/day G-CSF
Trial: 9028548
Drug: 16 micrograms/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 micrograms/kg/day G-CSF
Trial: 9028548
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of G-CSF
Trial: 9028548
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of G-CSF
Trial: 27781390
Drug: Multicomponent nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent nutritional supplement for 24 weeks
Trial: 1970107
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone measurement
Trial: 31317694
Drug: Frankincense consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frankincense consumption (500 mg pills, two times a day for 4 weeks)
Trial: 2686417
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin (200 mg every 12 hours)
Trial: 2686425
Drug: Intravenous ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ceftazidime (1 g every eight hours)
Trial: 2686417
Drug: Intravenous ceftazidime
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ceftazidime
Trial: 29436868
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy (10 l/min)
Trial: 22182228
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (VeC and CC)
Trial: 14517188
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (C)
Trial: 8222516
Drug: Noradrenaline infusion
RxNorm normalized name: noradrenaline hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline infusion
Trial: 15562199
Drug: HIM2 (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIM2 (0.125 mg/kg)
Trial: 12547873
Drug: HIM2 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIM2 (0.5 mg/kg)
Trial: 15562199
Drug: HIM2 (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIM2 (0.75 mg/kg)
Trial: 9430857
Drug: Loop diuretics
RxNorm normalized name: LOOP DIURETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop diuretics (torasemide, frusemide)
Trial: 7900662
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone (7 mg/kg)
Trial: 18339679
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg aspirin on alternate days
Trial: 9010986
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 1.8 mg/kg
Trial: 29905976
Drug: Rolapitant (IV)
DrugBank: Rolapitant (DB09291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rolapitant (IV) 18 mg
Trial: 29905976
Drug: Rolapitant (IV)
DrugBank: Rolapitant (DB09291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rolapitant (IV) 36 mg
Trial: 29905976
Drug: Rolapitant (IV)
DrugBank: Rolapitant (DB09291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rolapitant (IV) 54 mg
Trial: 25660991
Drug: Tapering DMARDs
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tapering DMARDs by 50% (arm 2)
Trial: 25660991
Drug: Stopping DMARDs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping DMARDs after 6 months tapering (arm 3)
Trial: 24518124
Drug: Irsogladine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irsogladine (4 mg/day)
Trial: 7850821
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) monotherapy
Trial: 20725056
Drug: Atenolol monotherapy
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol monotherapy
Trial: 19571804
Drug: HCTZ +
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HCTZ + atenolol combination therapy
Trial: 19571804
Drug: Atenolol +
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol + HCTZ combination therapy
Trial: 7623725
Drug: Pre-radiotherapy chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-radiotherapy chemotherapy (vincristine, procarbazine, methotrexate)
Trial: 7623725
Drug: Reduced dose
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced dose radiotherapy (25 Gy to the craniospinal axis)
Trial: 7623725
Drug: Post-radiotherapy chemotherapy
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-radiotherapy chemotherapy (vincristine and CCNU for high risk children)
Trial: 2259867
Drug: Amikacin 11
RxNorm normalized name: amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin 11 mg/kg bw
Trial: 2259867
Drug: Amikacin 15
RxNorm normalized name: amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin 15 mg/kg bw
Trial: 7377745
Drug: Sulfadiazine (SD)
RxNorm normalized name: Sulfadiazine
DrugBank: Sulfadiazine (DB00359)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfadiazine (SD) 500 mg twice daily
Trial: 7377745
Drug: Sulfamethoxazole (SM)
RxNorm normalized name: Sulfamethoxazole
DrugBank: Sulfamethoxazole (DB01015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole (SM) 1000 mg twice daily
Trial: 31991511
Drug: Vibegron 50
RxNorm normalized name: Vibegron
DrugBank: Vibegron (DB14895)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Vibegron 50 mg
Trial: 31991511
Drug: Vibegron 100
RxNorm normalized name: Vibegron
DrugBank: Vibegron (DB14895)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Vibegron 100 mg
Trial: 31991511
Drug: Vibegron 50
RxNorm normalized name: Vibegron
DrugBank: Vibegron (DB14895)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Vibegron 50 mg and 100 mg
Trial: 27641003
Drug: Deferiprone 16.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferiprone 16.7 mg kg‐1
Trial: 21244439
Drug: Kudzu extract
RxNorm normalized name: Aminobenzoic Acid/Black Cohosh Extract/Boron/Dong Quai Extract/Ginseng Extract, Korean/Hesperidin/Kudzu Extract/Licorice Extract/Resveratrol/Wild Yam Extract 50 MG-25 MG-25 MCG-25 MG-100 MG-50 MG-25 MG-37.5 MG-0.5 MG-25 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kudzu extract (total isoflavone dose of 750 mg/d)
Trial: 19961042
Drug: eperisone 300
RxNorm normalized name: acetaminophen / phenyltoloxamine citrate Oral Tablet [Perisine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eperisone 300 mg/day
Trial: 19961042
Drug: eperisone 150
RxNorm normalized name: acetaminophen / phenyltoloxamine citrate Oral Tablet [Perisine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eperisone 150 mg/day
Trial: 18190257
Drug: Lopinavir/ritonavir (LPV/r)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lopinavir/ritonavir (LPV/r) once-daily therapy
Trial: 3122575
Drug: Human menopausal
RxNorm normalized name: Human menopausal gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human menopausal gonadotropin (150 U administered hourly)
Trial: 25761501
Drug: Before treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Before treatment for intestinal parasites
Trial: 25761501
Drug: After successful
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After successful antiparasitic treatment
Trial: 23050945
Drug: Glucosamine (Artrox®)
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine (Artrox®) 625 mg twice daily
Trial: 15908764
Drug: rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 10 mg once daily
Trial: 15908764
Drug: ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 300 mg once daily
Trial: 12479049
Drug: External RF
RxNorm normalized name: Aminosyn-RF 5.2 %, Sulfite-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External RF hyperthermia (ERFH) combined with alpha 1-adrenergic receptor blocker Terazosin for 12 weeks
Trial: 2777428
Drug: Liquid-filled capsules
RxNorm normalized name: RP Scherer Paracetamol Liquid-Filled Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid-filled capsules (20 mg)
Trial: 2777428
Drug: Slow-release tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release tablets (20 mg)
Trial: 1120220
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 tablets
Trial: 31345559
Drug: propofol +
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: propofol + ketamine 0.4 mg/kg
Trial: 7851554
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of laparoscopy and laparoscopic ultrasound
Trial: 2693432
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course tobramycin therapy
Trial: 30600526
Drug: Intranasal sufentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal sufentanil (0.4 μg/kg)
Trial: 21319897
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) intervention
Trial: 19843674
Drug: Energy intake
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy intake from a FFQ administered approximately five years after entry
Trial: 9658729
Drug: Nadroparin (home
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin (home treatment)
Trial: 8018909
Drug: Intermittent cyclic
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent cyclic regimen of intermediate-dose methotrexate (MTX) plus 6-mercaptopurine (6MP)
Trial: 8018909
Drug: Conventional continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional continuous administration of low dose of MTX plus 6MP
Trial: 8018909
Drug: Three-drug induction
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug induction therapy consisting of vincristine (VCR), prednisone (PDN), and L-asparaginase (L-ASP)
Trial: 4129562
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg dose of Delta 1 testololactone
Trial: 4129562
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg dose of Delta 1 testololactone
Trial: 8498662
Drug: Intravenous alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alfentanil (PCA)
Trial: 3031226
Drug: Chest radiation
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest radiation therapy (4,800 rad in a split-course scheme)
Trial: 3031226
Drug: Chemotherapy without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy without interruption (maintenance chemotherapy with cyclophosphamide and VP-16)
Trial: 3031226
Drug: Preinduction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preinduction treatment volume or postinduction reduced tumor volume (radiation treatment portals based on tumor extent)
Trial: 19147232
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide implant
Trial: 16541243
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg caffeine
Trial: 12842055
Drug: Urogynaecologist treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urogynaecologist treatment
Trial: 8780282
Drug: Ondansetron (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (1, 4, or 8 mg intravenously before induction of anesthesia)
Trial: 1621434
Drug: IgG-anticardiolipin-antibodies in
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG-anticardiolipin-antibodies in patients with cerebral and peripheral artery disease (group C)
Trial: 1621434
Drug: IgG-anticardiolipin-antibodies in
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG-anticardiolipin-antibodies in patients with peripheral artery disease only (group B)
Trial: 22449804
Drug: Xylitol lozenges
RxNorm normalized name: xylitol Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol lozenges (6 g/day) for 33 months
Trial: 18848670
Drug: Quick Start
RxNorm normalized name: Cal-Quick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quick Start (QS) - immediate, directly observed OC pill ingestion in the clinic
Trial: 18848670
Drug: Conventional Start
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Start (CS) - conventional initiation of the OC pill
Trial: 11324096
Drug: Universally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Universally administered classroom program
Trial: 8983588
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (five different techniques used)
Trial: 8983588
Drug: Three-dimensional treatment
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-dimensional treatment planning system
Trial: 1722779
Drug: HES‐A (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES‐A (500 ml daily for 9 days)
Trial: 1722779
Drug: HES‐B (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HES‐B (500 ml daily for 8 days)
Trial: 7327086
Drug: Thrice weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice weekly levo‐alpha‐acetylmethadol (LAAM)
Trial: 30182753
Drug: D3-Vitamin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D3-Vitamin (100 μg/day)
Trial: 26151421
Drug: 600,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600,000 IU intramuscular (i.m.)
Trial: 26151421
Drug: 200,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200,000 IU intramuscular (i.m.)
Trial: 26151421
Drug: 200,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200,000 IU oral (p.o.)
Trial: 22872657
Drug: Slow intravenous
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow intravenous infusion of lactated Ringer solution (1.2 ± 0.3 litres)
Trial: 22872657
Drug: Dehydration (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dehydration (no intravenous infusion)
Trial: 19213607
Drug: Brachytherapy I-125
RxNorm normalized name: HSA I-125
DrugBank: Albumin iodinated I-125 serum (DB09429)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brachytherapy I-125 with rectal protection using hyaluronic acid (HA)
Trial: 17941364
Drug: MimyX cream
RxNorm normalized name: MIMYX CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MimyX cream (PDT or IPL)
Trial: 15551893
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg midazolam (1 ml)
Trial: 15551893
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg midazolam (1 ml)